UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 401

Sortiert nach

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

Osteoporosis international, 2011-02, Vol.22 (2), p.567-576

2011

Volltextzugriff (PDF)

Comment prendre en charge les sténoses acquises du conduit auditif externe

Annales d'oto-laryngologie et de chirurgie cervico-faciale, 2009-11, Vol.126 (5), p.278-282

2009

Volltextzugriff (PDF)

FRI0165 Effectiveness and Safety of Biosimilar Infliximab (CT-P13) in A Real-Life Setting in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.489-489

2016

Volltextzugriff (PDF)

FRI0166 Persistence of Biologic Therapy for Patients with Active Rheumatoid Arthritis: Data from The Romanian Registry of Rheumatic Diseases

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.489-490

2016

Volltextzugriff (PDF)

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis

Rheumatology (Oxford, England), 2022, Vol.61 (12), p.4741

2022

Volltextzugriff (PDF)

FRI0171 Evaluating Treatment Efficacy in Rheumatoid Arthritis: Interrelation Disease Activity – Functional Status – Utility

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.491-491

2016

Volltextzugriff (PDF)

Acute pain: a multifaceted challenge - the role of nimesulide

Current medical research and opinion, 2016-01, Vol.32 (1), p.23-36

2016

Volltextzugriff (PDF)

AB0686 Can Fatigue BE Used as A Unique Disease Activity Marker in Ankylosing Spondylitis Patients?

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1032-1032

2014

Volltextzugriff (PDF)

FRI0424 Accessibility To Biological Therapy for Patients with Ankylosing Spondylitis in Romania Is Influenced by Area of Residence, Socio- Economic and Demographic Factors

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.589-589

2016

Volltextzugriff (PDF)

FRI0220 Sustained clinical efficacy after multiple courses of rituximab in rheumatoid arthritis patients with inadequate response to tumour necrosis factor inhibitors: 2-year data from the repeat (repeated courses in routine clinical practice) study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A447-A448

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

Value in health, 2014-11, Vol.17 (7), p.A379-A379

2014

Volltextzugriff (PDF)

Parathyroid cysts, a rare condition: a case report and review of the literature

Chirurgia (Bucharest, Romania : 1990), 2011-01, Vol.106 (1), p.127-129

2011

Volltextzugriff (PDF)

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1582-1587

2005

Volltextzugriff (PDF)

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1357-1362

2006

Volltextzugriff (PDF)

THU0431 Area of Residence and Socio-Economic Factors Significantly Affect ACCESS to Biological Therapy for Rheumatoid Arthritis Patients in Romania

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.331-331

2014

Volltextzugriff (PDF)

SAT0066 Value of Antinuclear Antibodies in the Therapeutic Efficacy of Biologics in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.672-672

2015

Volltextzugriff (PDF)

FRI0107 Romanian Registry of Rheumatic Diseases: Efficacy and Safety of Biologic Therapy in Rheumatoid Arthritis

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.458-458

2015

Volltextzugriff (PDF)

THU0162 Patterns of Clinical Response Predict Failure of TNF Inhibitor Treatment in Rheumatoid Arthritis: Data from a Longitudinal Observational Study in Romania

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A218-A218

2013

Volltextzugriff (PDF)

OP0026 Sustained and cumulated response over time in ra patients treated with rituximab after initial failure of anti-TNF agents

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.61-62

2013

Volltextzugriff (PDF)

THU0106 Rituximab after first anti-TNF failure is more efficient with high impact in reducing time and costs to achieve superior rates of low disease activity and remission

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.190-190

2013

Volltextzugriff (PDF)

AB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.669-669

2013

Volltextzugriff (PDF)

THU0163 Disease Flares Predict the Change to Second Line Therapy in Rheumatoid Arthritis: 9-Year Data from a Longitudinal Observational Study

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A218-A218

2013

Volltextzugriff (PDF)

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study

Annals of the rheumatic diseases, 2009-07, Vol.68 (7), p.1146-1152

2009

Volltextzugriff (PDF)

AB0684 Comparison of Two Referral Strategies for the Diagnosis of Axial Spondyloarthritis in Romania: the Rabbit Study

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1031-1031

2014

Volltextzugriff (PDF)

Obesity Discrimination in the Recruitment Process: "You're Not Hired!"

Frontiers in psychology, 2016-05, Vol.7, p.647-647

2016

Volltextzugriff (PDF)

1 – 25 von 401

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(355)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(182)
Humans
(117)
Life Sciences & Biomedicine
(117)
Technology
(64)
Engineering
(56)
Engineering, Electrical & Electronic
(56)
Female
(56)
Male
(53)
Middle Aged
(45)
Adult
(42)
Physical Sciences
(34)
Rheumatology
(34)
Medicin Och Hälsovetenskap
(33)
Treatment Outcome
(28)
Rheumatoid Arthritis
(25)
Aged
(24)
Biological And Medical Sciences
(22)
Biochemistry & Molecular Biology
(21)
Physics
(21)
Medical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

Comment prendre en charge les sténoses acquises du conduit auditif externe

FRI0165 Effectiveness and Safety of Biosimilar Infliximab (CT-P13) in A Real-Life Setting in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis

FRI0166 Persistence of Biologic Therapy for Patients with Active Rheumatoid Arthritis: Data from The Romanian Registry of Rheumatic Diseases

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis

FRI0171 Evaluating Treatment Efficacy in Rheumatoid Arthritis: Interrelation Disease Activity – Functional Status – Utility

Acute pain: a multifaceted challenge - the role of nimesulide

AB0686 Can Fatigue BE Used as A Unique Disease Activity Marker in Ankylosing Spondylitis Patients?

FRI0424 Accessibility To Biological Therapy for Patients with Ankylosing Spondylitis in Romania Is Influenced by Area of Residence, Socio- Economic and Demographic Factors

FRI0220 Sustained clinical efficacy after multiple courses of rituximab in rheumatoid arthritis patients with inadequate response to tumour necrosis factor inhibitors: 2-year data from the repeat (repeated courses in routine clinical practice) study

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania

Parathyroid cysts, a rare condition: a case report and review of the literature

Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison

THU0431 Area of Residence and Socio-Economic Factors Significantly Affect ACCESS to Biological Therapy for Rheumatoid Arthritis Patients in Romania

SAT0066 Value of Antinuclear Antibodies in the Therapeutic Efficacy of Biologics in Rheumatoid Arthritis

FRI0107 Romanian Registry of Rheumatic Diseases: Efficacy and Safety of Biologic Therapy in Rheumatoid Arthritis

THU0162 Patterns of Clinical Response Predict Failure of TNF Inhibitor Treatment in Rheumatoid Arthritis: Data from a Longitudinal Observational Study in Romania

OP0026 Sustained and cumulated response over time in ra patients treated with rituximab after initial failure of anti-TNF agents

THU0106 Rituximab after first anti-TNF failure is more efficient with high impact in reducing time and costs to achieve superior rates of low disease activity and remission

AB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data

THU0163 Disease Flares Predict the Change to Second Line Therapy in Rheumatoid Arthritis: 9-Year Data from a Longitudinal Observational Study

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study

AB0684 Comparison of Two Referral Strategies for the Diagnosis of Axial Spondyloarthritis in Romania: the Rabbit Study

Obesity Discrimination in the Recruitment Process: "You're Not Hired!"

Suchergebnisse filtern